Diagnostic and prognostic value of myocardial perfusion imaging in patients with known or suspected stable coronary artery disease

Echocardiography

Volumn 17, Issue 6 I, 2000, Pages 587-595

  Amanullah, Aman M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UPMC Horizon UPMC Horizon Shenango Valley   (United States)

Author keywords

Coronary artery disease; Myocardial perfusion; Prognosis; Single photon emission computed tomography

Indexed keywords

ADENOSINE; CORONARY VASODILATING AGENT; DIPYRIDAMOLE; RADIOISOTOPE; TECHNETIUM 99M; THALLIUM 201;

ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EXERCISE TEST; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

EID: 0033814538     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8175.2000.00587.x     Document Type: Article

References (78)

1. State-of the-art myocardial perfusion imaging
2. Exercise thallium-201 perfusion scintigraphy in the assessment of ischemic heart disease
3. Myocardial perfusion scintigraphy during maximal coronary artery vasodilation with adenosine
4. Current status of non-invasive techniques for the diagnosis of myocardial ischemia
5. Myocardial perfusion imaging during pharmacologic stress testing
6. Detection and evaluation of coronary artery disease by thallium-201 myocardial perfusion scintigraphy
7. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography
8. Quantitative thallium201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease
9. Detection of coronary artery disease
10. Quantitative thallium-201 exercise scintigraphy for detection of coronary artery disease
11. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201
12. Quantitative planar thallium-201 stress scintigraphy: A critical evaluation of the method
13. Determination of the quantitative thallium imaging variables that optimize detection of coronary artery disease
14. Assessment of left ventricular wall motion in angina pectoris by two-dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography
15. Factors affecting sensitivity and specificity of a diagnostic test: The exercise thallium scintigram
16. The declining specificity of exercise radionuclide ventriculography
17. Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: A multicenter trial
18. Stress thallium-201 transaxial emission computed tomography: Quantitative versus qualitative analysis for evaluation of coronary artery disease
19. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease
20. Effects of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: Analysis of 461 patients
21. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease
22. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: Optimization and prospective validation of a new technique
23. Exercise thallium-201 perfusion scintigraphy in the assessment of coronary artery disease
24. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: Correlation with echocardiography and rest thallium scintigraphy
25. Artifacts in SPECT: Myocardial perfusion imaging
26. Comparison of technetium-99m methoxy isobutyl isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods
27. Technetium-99m hexakis 2-methoxiisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging
28. European multi-centre comparison of thallium-201 and technetium 99m methoxy isobutylisonitrile in ischaemic heart disease
29. Exercise myocardial perfusion scintigraphy with technetium-99m methoxy isobutylisonitrile: A comparative study with thallium-201
30. Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging
31. 201Tc 2-methoxy-isobutylisonitrile: A direct comparison in normal individuals and patients with coronary artery disease
32. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual- isotope myocardial perfusion single photon emission computed tomography: A clinical validation study
33. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial
34. Serial thallium-201 myocardial imaging after dipyridamole infusion: Diagnostic utility in detecting coronary stenoses and relationship to regional wall motion
35. Thallium-201 imaging after dipyridamole in patients with coronary multivessel disease
36. Tomographic thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilation with intravenous dipyridamole: Comparison of qualitative and quantitative approaches
37. Comparison of dipyridamole and treadmill exercise for enhancing thallium-201 perfusion defects in patients with coronary artery disease
38. Noninvasive detection of coronary artery disease by myocardial imaging with thallium-201: The significance of pharmacologic interventions
39. Respective sensitivity and specificity of 201 TI myocardial scintigraphy during effort, after injection of dipyridamole and at rest: Comparison in 70 patients who had undergone coronary radiography
40. Split dose thallium-201 dipyridamole imaging: A new technique for obtaining thallium images before and immediately after an intervention
41. Radionuclide imaging after coronary vasodilation: Myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole
42. Quantitative analysis of dipyridamole-thallium images for the detection of coronary artery disease
43. Thallium-201 myocardial imaging during pharmacologic coronary vasodilation: Comparison of oral and intravenous administration of dipyridamole
44. Ischemic ST-segment changes after dipyridamole infusion
45. Safety and diagnostic accuracy of dipyridamole thallium imaging in the elderly
46. Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease
47. Analysis of thallium-201 single photon emission computed tomography after intravenous dipyridamole using different quantitative measures of coronary stenosis severity and receiver operative characteristics curves
48. Pharmacologic vasodilator stress alternatives for cardiac perfusion imaging
49. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: Diagnostic efficacy in detection of coronary artery disease
50. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging
51. Identification of extensive coronary artery disease in women by exercise single photon emission computed tomographic (SPECT) thallium imaging
52. Identification of high risk patients with left main and three-vessel coronary artery disease using stepwise discriminant analysis of clinical, exercise and tomographic thallium data
53. Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT
54. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain
55. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease
56. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography
57. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: Comparison with cardiac catheterization
58. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: A comparison with cardiac catheterization
59. Prognostic value of thallium-201 single photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect: Study in 1,926 patients with a follow-up at 33 months
60. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease
61. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease
62. Independent and incremental prognostic value of exercise singlephoton emission computed tomographic (SPECT) thallium imaging in coronary artery disease
63. Predictors of outcome of medically treated patients with left main/3-vessel disease by coronary angiography
64. Predictors of outcome in high-risk medically treated patients with diabetes mellitus
65. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single photon emission computed tomography
66. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification
67. Adenosine SPECT in patients without known coronary artery disease: Prediction of cardiac events and test utilization
68. Incremental prognostic value of myocardial perfusion SPECT for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction
69. Incremental prognostic value of adenosine myocardial perfusion imaging in women
70. Enhanced prognostic stratification of patients with left ventricular hypertrophy using myocardial perfusion imaging
71. The evaluation of patients more than five years after coronary bypass surgery: Potential cost savings of a nuclear exercise testing approach
72. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
73. The oldest old
74. Coronary artery disease in geriatric cardiology
75. Clinical spectrum and diagnostic techniques of coronary heart disease in the elderly
76. Prognostic value of dipyridamole thallium-201 imaging in elderly patients
77. Prognostic value of exercise and adenosine myocardial perfusion SPECT in the very elderly